Dr. Reddy's Laboratories Ltd ADR
(RDY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RDY | BBIO | SUPN | ||
| Company | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 14.14 | 70.07 | 50.01 | ||
| High | 14.14 | 70.63 | 51.99 | ||
| Low | 13.84 | 67.59 | 50.01 | ||
| Latest | 14.08 | 68.05 | 51.65 | ||
| Change | +0.11 | +4.32 | +2.28 | ||
| % Change | +0.79% | +6.78% | +4.62% | ||
| Volume | 2,901,000 | 4,742,000 | 893,900 | ||
| 20-Day Average Volume | 2,130,270 | 3,304,820 | 755,135 | ||
| Previous Close | 13.97 | 63.73 | 49.37 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.50 | 76.48 | 49.74 | ||
| 20-Day Raw Stochastic | 95.49% | 28.19% | 83.69% | ||
| 20-Day Relative Strength | 56.91 | 40.86 | 59.71 | ||
| Weighted Alpha | +1.21 | +105.36 | +43.96 | ||
| Today's Opinion | 40% Sell | 56% Buy | 96% Buy | ||
| Previous Opinion | 48% Sell | 48% Buy | 72% Buy | ||
| Last Month's Opinion | 80% Sell | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.92% since 01/30/26 | -11.93% since 01/30/26 | +7.25% since 01/30/26 | ||
| Low | 12.95 on 02/02/26 | 62.84 on 02/05/26 | 47.29 on 02/03/26 | ||
| High | 14.14 on 02/06/26 | 80.00 on 02/03/26 | 51.99 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | +1.59% since 01/06/26 | -8.03% since 01/06/26 | +4.85% since 01/06/26 | ||
| Low | 12.81 on 01/20/26 | 62.84 on 02/05/26 | 47.29 on 02/03/26 | ||
| High | 14.14 on 02/06/26 | 81.32 on 01/22/26 | 52.50 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +4.53% since 11/06/25 | +8.48% since 11/06/25 | +9.28% since 11/06/25 | ||
| Low | 12.81 on 01/20/26 | 60.55 on 11/07/25 | 44.05 on 11/18/25 | ||
| High | 14.32 on 12/23/25 | 81.32 on 01/22/26 | 52.50 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +5.63% since 08/06/25 | +51.86% since 08/06/25 | +21.70% since 08/06/25 | ||
| Low | 12.81 on 01/20/26 | 44.10 on 08/07/25 | 40.26 on 08/08/25 | ||
| High | 15.06 on 09/17/25 | 81.32 on 01/22/26 | 57.65 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,755,926 | 13,113,848 | 2,961,560 | ||
| Shares Outstanding, K | 834,938 | 192,709 | 57,339 | ||
| Annual Sales | 3,811,000,000 | 221,900,000 | 661,820,000 | ||
| Annual Net Income | 663,000,000 | -535,760,000 | 73,870,000 | ||
| Last Quarter Sales | 977,400,000 | 120,700,000 | 192,100,000 | ||
| Last Quarter Net Income | 135,500,000 | -182,740,000 | -45,120,000 | ||
| 60-Month Beta | 0.35 | 1.13 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.19 on 10/24/25 | -0.95 on 10/29/25 | 1.01 on 11/04/25 | ||
| Latest Earnings Date | 05/08/26 | 02/19/26 | 02/24/26 | ||
| Most Recent Dividend | 0.071 on 07/25/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 07/25/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.14 | 0.00 | 23.18 | ||